Holos Integrated Wealth’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$107K Hold
6,500
– – 0.05% 121
2026
Q2
$94.2K Hold
6,500
– – 0.04% 123
2026
Q1
$52.4K Hold
6,500
– – 0.03% 154
2025
Q4
$76.4K Hold
6,500
– – 0.04% 107
2025
Q3
$59.2K Sell
6,500
-20,000
-75% -$140K 0.03% 111
2025
Q2
$154K Hold
26,500
– – 0.09% 72
2025
Q1
$251K Hold
26,500
– – 0.16% 54
2024
Q4
$437K Buy
+26,500
New +$412K 0.3% 39

Other funds holding NEO

Holos Integrated Wealth's NEO Position: Q3 2026 in Review

Holos Integrated Wealth held its NeoGenomics (NEO) position steady in Q3 2026 at 6,500 shares worth $107K. The position accounts for 0.05% of the portfolio, ranked #121.

Holos Integrated Wealth first reported a position in NEO in Q4 2024 and has held it in 8 quarters since. The position peaked at $437K in Q4 2024. 47 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Holos Integrated Wealth held 6,500 shares of NeoGenomics worth $107K as of Q3 2026.
  • Holos Integrated Wealth left its NeoGenomics share count unchanged in Q3 2026.
  • NeoGenomics made up 0.05% of Holos Integrated Wealth's portfolio in Q3 2026, its #121 holding.
  • Holos Integrated Wealth first reported a position in NeoGenomics in Q4 2024 and has held it in 8 quarters since.
  • Holos Integrated Wealth's NeoGenomics position peaked at $437K in Q4 2024.
  • 47 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Holos Integrated Wealth's 13F filing for Q3 2026, filed 23 Oct 2026.